Prosecution Insights
Prosecution Insights
Technology areas: Biotechnology & Pharmaceuticals • Medical Devices & Mechanical Engineering
5 pending office actions • 3 clients • 5 examiners • 4 art units • 0 of 5 (0%) have an AI response strategy ready
SISKINDS LLP specializes in the Biotechnology & Pharmaceuticals sector, having managed 193 career applications. The firm maintains a resolved allowance rate of 90.44 percent, which reflects the frequency of success in securing patent protections within these technical fields. This rate is based on a portfolio that demonstrates the firm's activity in life sciences. The 193 career applications show a presence in this specialized market.
On average, the firm receives 2.73 office actions per allowance. This figure suggests a prosecution cycle for biotechnology and pharmaceutical patents, which are subject to examination. There are currently 5 pending office actions under management. The combination of a 90.44 percent allowance rate and an average of 2.73 office actions per allowance indicates a path to patent grants. These metrics highlight the firm's ability to navigate examiner hurdles.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 1 (20%) |
| §102 only | 1 (20%) |
| Multi-statute (no §101) | 3 (60%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| WALTER, AUDREY BRADLEY | 1 | 80.9% | +23.9% |
| IANNUZO, NATALIE NMN | 1 | 12.5% | +71.4% |
| DEKARSKE, MADELINE MCGUIRE | 1 | 0.0% | +0.0% |
| ISMAIL, REHANA | 1 | 75.8% | +34.8% |
| DOUBRAVA, JOHN A | 1 | 76.9% | +26.4% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 4 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18848610 | SPORT PADDLE | WALTER, AUDREY BRADLEY | — |
| 18572696 | CANNABINOID-CONTAINING FORMULA FOR SKIN CARE | IANNUZO, NATALIE NMN | — |
| 18560206 | PSILOCYBIN AND PSILOCIN CONJUGATES FOR TREATMENT OF MENTAL ILLNESSES | DEKARSKE, MADELINE MCGUIRE | — |
| 18007935 | RIGID CANNABIDIOL ANALOGUES AS POTENT MODULATORS OF CANNABINOID RECEPTORS AND USES THEREOF | ISMAIL, REHANA | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 4 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18848610 | SPORT PADDLE | WALTER, AUDREY BRADLEY | — |
| 18572696 | CANNABINOID-CONTAINING FORMULA FOR SKIN CARE | IANNUZO, NATALIE NMN | — |
| 18007935 | RIGID CANNABIDIOL ANALOGUES AS POTENT MODULATORS OF CANNABINOID RECEPTORS AND USES THEREOF | ISMAIL, REHANA | — |
| 17608656 | FEEDING TUBE WITH INTEGRATED STYLET | DOUBRAVA, JOHN A | — |
| Client (Assignee) | Pending OAs |
|---|---|
| London Pharmaceuticals | 3 |
| 2 Pong Inc. | 1 |
| Bles Biochemicals Incorporated | 1 |
| Art Unit | Apps |
|---|---|
| 1653 | 1 |
| 1622 | 1 |
| 1625 | 1 |
| 3783 | 1 |
| App # | Title | Client | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|---|
| 18848610 | SPORT PADDLE | 2 Pong Inc. | WALTER, AUDREY BRADLEY | §102§103 | Non-Final OA | — | Pending | Sep 19, 2024 | |
| 18572696 | CANNABINOID-CONTAINING FORMULA FOR SKIN CARE | London Pharmaceuticals And Research Corporation | IANNUZO, NATALIE NMN | 1653 | §102§103§112 | Non-Final OA | — | Pending | Dec 20, 2023 |
| 18560206 | PSILOCYBIN AND PSILOCIN CONJUGATES FOR TREATMENT OF MENTAL ILLNESSES | London Pharmaceuticals And Research Corporation | DEKARSKE, MADELINE MCGUIRE | 1622 | §103§112 | Non-Final OA | — | Pending | Nov 10, 2023 |
| 18007935 | RIGID CANNABIDIOL ANALOGUES AS POTENT MODULATORS OF CANNABINOID RECEPTORS AND USES THEREOF | London Pharmaceuticals And Research Corporation | ISMAIL, REHANA | 1625 | §101§102§112 | Non-Final OA | — | Pending | Dec 02, 2022 |
| 17608656 | FEEDING TUBE WITH INTEGRATED STYLET | Bles Biochemicals Incorporated | DOUBRAVA, JOHN A | 3783 | §102 | Non-Final OA | — | Pending | Nov 03, 2021 |
IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial